In one study, the concordance was higher between ctDNA and metastatic site tissue-DNA than between ctDNA and primary tumor DNA (78% versus 65% for TP53, 100% versus 74% for KRAS, and 100% versus 87% for PIK3CA) [35]. This evidence concerns the gene TP53 and neoplasm.